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1. INT I tODUCTION 
Tissue-type plasnlinol~¢n activator (t-PA), an i lnpor- 
tailt t l lcrapeutic thrombolyt ic  ~lgent [1], is clc,'ircd 
rapidly from the circulation. The plasm<'l hull-l ife of t- 
PA is only 3--5 inin [2..-4], Tile liver is the major site for 
the clearance of t-PA [2-4] but the ineclmnism is not 
yet established. Evitlencc has emerged recently for at 
least two receptor system.~ for t .PA, Hepatic en- 
dothel ial  cells contain a in;.annose receptor that is in- 
volved in the clearance of t-PA [5,6]. Liver 
parenchytnal  cells appear to trove a .~pecific receptor for 
t -PA [5,7]; this receptor probably recotlnizcs the finger 
and growth factor domains  of  t -PA [8], 
We trove previously suggested that the hi,gh concen.  
trat ion of plastninogen activator inhibitor (PA l - l )  in 
human liver may have a role in the clearance of t -PA 
[91. Studies in the human hepatoma cell line, Hep G2, 
have shown that t -PA uptake occurs after complex for- 
mat ion with PAI.1 in the e×tracellular matri× of these 
cells [10,11], We have established that the uptake of 
pre- formed t -PA-PAI-1 comple× by the isolated perfus- 
ed rat liver occurs twice as rapidly as that of free t -PA 
[121. It was notable that the most significant difference 
in the clearance of  the two proteins was the stronger 
bind ing of  complex to liver cells, suggesting the 
presence of  a receptor specific for the comple×. Here 
we present evidence for such a receptor on human 
hepatocytes. 
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2, MA'TERIAI .S AND METHODS 
2 I, I~¢ltge#ttJ" 
[ I " I i F -PA  wiis ~UPl)lied by Al l lcr.dlanl (f~.40-l,lttOCi/lltin01}, 
Sii'lglc-,,:h;.ihl ¢conlbil l ; lnt htlnlan [-ll,.'k ',~,';l~, f rom (ienenl¢¢h T.PA,, 
l lA l . l  conlp lex wa~ pnrif ied tronl  tH' l l l l ' I t l  ¢c11,~ a,~ d¢~¢i'ibed 
i~reviotl~l) ' and contahlcd no tlei¢~lgbl¢ free t .PA  ~1' [1Al. I  l i21, 
Radio labei led t -PA-PA I - I  ,,wi~ prel3arcd b7 inenbathtg ( i l~ l l l . PA  
v,.iih I:1¢p U2 exlracellnlgl' n lu lr ix ,  wll ich ¢onl~lin,~ a~iive l lA i - I  l iOl 
for 2 h gt ]7 °C, The [ :~1 ] t -PA-PA I - I  ¢o1'ilp1¢,~ war. aili.ily~¢d I~y S ])S, 
PAGE gild autor,'ldio,t;taphy gild8(~:!}{Io'o f the r:idiol'.ibel was pr¢. 
sent as ¢oinl~lex PAI-I wa~ Imrit'ied froth hum:ut endnthelial cells 
• "llld ,lctivgle¢l by guanidine '.is tles,:rihcd pl'cViOur, ly [I 31, tJ-PA (t we. 
chain) was from Medac Ginbl-l, Ilan'lburB, and u.PA.PAI.I ¢Oillplcx 
was prepared by incubaiion of u.PA wit I1 i~uanidine activated I'AI-1 
for 1 h at 22~C, Complex forln:ltion wg,~ assessed by SI])S.PAf.IE, 
followed by inmiunoblntiing or zynaography [12], ~littl w~ls lt07'0 
complete, 
2,2, Ls-olation Qf human helmtoc.~tes 
Huntgn h¢l~,'ltocyies were i~Ohlled :trier coll.*tgenase dispersion of 
20-30 g pieces of liver tissue, oblained front renal donors, as describ- 
ed previously f14}, The heprtlocytes, 90Olo viable by "rrypan blue ex- 
clusion, were wgsi'le~:l and restl.~pended in binding meditin~ (.see below) 
for 15-30 rain at 37°C 1151 mid kel~t at 4'>C, 
2.3, Hep G2 cells 
The hnnma lie,t~atOlilg cells, Hop G2, were nmini~ined in DMEM 
suppleinented with 10%% fetgl calf serum, 100 U/ml penicillin ~lnd 
100/xg/ml strel)toinycin trader 5~10 COz:95010 O~ atmo,~l~here, For
preparation of cell suspension, the cells (90~o conl'luent in 24-~vell 
plates) were washed 3times in 10 mM phosphate buffer pH 7,2 with 
0.15 M NaCI (PBS) and incubated with 3 mM EDTA in PBS for 
10 rain at 37~C, DMEM was added and the cells were dislodged from 
the culture dish with a plastic pipette. The resultinll cell suspension 
was washed 3 × witt~ DMEM ~nd the cells were 90-95~/~ viable as 
assessed by Trypan blue c~;clusion, 
2,4. Binding ass'ay 
Washed cells (10 s hepatocyles orHep G2), resuspended in binding 
medium (1 mg/ml BSA, 0.01010 Tween 80 in DMEM), were incubated 
at 4°C with !igands. ~'~!.t-PA-P.a.I-I complex was added znd e~eh 
sample was mi~ed for 2 h at 4°C, The cells were washed ( × 3) with 
PBS at 4°C, lysed with 1 M NaOH and radioactivity counted. 
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Fig, t, Specit'ic bindint~ of [i:~Iit-PA-PAI-I ct~nlplex (0.77 aM) let 
l luman hepatocytes expressed as fmol bound per 10 "~ c¢tls, competed 
by increasin8 concentrations (nh,'l) o f  unlabelled t-PA-PAI- I  
comple.~, Values shown are tile :nea:~ of duplicate determinations 
SD and are typical of  the three such experiments performed, Inset, 
Seatchard plot of  the data, 
2,5, lnter/lali~uttotl assay 
Blinding, was as in Section 2,4 and the cells were washed with PBS 
at 4°C as above. The total counts of the bound l igand were determin- 
ed, Bit~.ding ntedium was then added and each sample was incubated 
at 37°C for up to 2 h, At various t ime points, the cells were centrifug- 
ed (900 × g at 4°C), The supernatant and that obtained after treating 
the cells with 0,02e/o trypsin in PBS (30 rain at 4°C) was counted, as 
was the cell pellet after lysis with 1 M NaOH 
3. RESULTS 
The binding of [~2~I]t-PA-PAI-I complex to human 
hepatocytes, in the presence of different concentrations 
of unlabelled t-PA-PAI-I complex, was analysed 
(Fig. 1). Scatchard analysis indicated specific and 
saturable binding, with a Ka of 0.87 __. 0.09 nM and 
74000 _ 11000 binding sites per cell (Fig. 1, inset). The 
binding was temperature-dependent and equilibrium 
was achieved at 4°C after 2 h (data not shown). After 
binding at 4°C, incubatio~l at 37°C allowed rapid up- 
take (maximal at 30 min) and degradation of [tz~I]t- 
PA-PAI-1 complex (Fig. 2). The uptake was inhibited 
totally by 0.5 mM chloroqaine (data not shown). 
Competitive binding assays demonstrated that t-PA, 
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Fig, 2. Ilnel'nali/z;th~l~ t~f rcccpit,r.bound [t:~l]t-PA.PAl. I  complex, 
lhlm;llt hCl+atoc)le., x~,,,:lC iltcUbalcd for 2 h at ,t+( . x~ith [ t-'~III-PA. 
F'AI+I cOtllplex. Th.,: ~:,;lls ',verc then xva,,h,..tl and inetlbalcd :,it ~7°(" 
in binding incdittlt'~ for the indicated tithes. 'rite d;fla are CXl'Jt'c'~cd as 
perc¢lttZlgc of the tot,d cotlntr, bouttd to the ccll,~ after 2 h at 4°( '. 
(o) I~,e¢cplor.bound IiF:and (tryptin.wn,~itive), (&) cdl-a~so¢iatcd 
ligand (not setl~itive to tryp~,in wash) and (B) released ligaud in the 
s l lpe l 'n l i t i l l l l  
u-PA, u-PA-PAI-I complex and PAl- I ,  either latent or 
guanidine-activated, did not compete with [t:'~l]t-PA- 
PAl-1 binding, even at the relatively high concentra- 
tions used (Table I). 
Comparable data were achieved with suspensions of 
Hep G2 cells; the Kd was 0.98 =*- 0.06 nM t-PA-PAI.!  
and there were 70000 ± 8600 binding sites per cell. Rat 
hepatocytes also showed comparable affinity for com- 
plex (Kd 0.86 :t- 0.05 nM) but the number of binding 
sites per cell was lower (10000-25000). No specific bin- 
ding of  t-PA-PAI-I  to the human lymphoma cell line 
U937 was detectable (data not shown). 
4, DISCUSSION 
Evidence is presented for a t-PA-PAI-1 receptor on 
human hepatocytes. The receptor is saturable and of 
Table I 
Specificity of [~'~'~Ilt-PA-PAI-I comple× bhtding to Ituman 
hcpatocytes 
Competitor (nM) [t2~I]t-PA-PAI-1 bound (°7o residual 
( fmol/10 ~ hepatocytes) binding) 
None 6,51 ± 0.40 100 
t-PA-PAI- I  16 2,97 .1- 0.40 46 
t-PA 700 7,74 _+. 0.50 118 
u-PA 700 6,59 ± 0.13 101 
u-PA-PAI- I  200 6.50 ± 0,01 100 
PAl-1 700 5.93 ~ 0,16 91 
PAI-I  (activated) 700 6.77 ~ 0.01 10 n 
Human hepatocytes were incubated with [12~I]t-PA-PAI-! complex 
(0,77 nM) in the absence or presence of  unlabelled competitors. Cell- 
bound radioactivity was determined as described in Section 2. Results 
are expressed as the mean ± standard deviation of duplicate 
determinations of 3 separate ×periments. 
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high afl'inily, Further, it pm'licilxtlc,~ in ~lw Ul',lakc and 
dcl~,radalio~ of toI 'A. I 'AI - I  Thc~c l'ii~din.g,~ cxphtin illltl 
cx l¢ I id  (till' Drcvio l l ' ,  data,  which showed tha l  lh¢ tip.. 
l ake  or  t.PA-PAI.,I i l l lh¢ i'~ohtlcd pcr fu . .¢d rat l i ver  
was even more  rap id  lhan  lhat  o f  f rcc  I -PA  [12], 
This receptor sySl¢ll~ app¢; l rs  lt~ |i¢ ,q~¢cil'i¢ l o r  IoI~A ., 
PAl.,1 complex, I:r¢¢ t-PA or PAI- I  did not compclc 
wilh binding, even wl~ctl l:~rcs¢i~l m a lO(}O-fohl cxo:ss 
over labelled t-PA-PAI-I. The  cxist¢ll¢¢ of :.i r¢ceplor 
for t-PA in complex with its principal inhibitor is in line 
with the knowil mcchanisn~ of ,~¢l'inc protcasc 
clearance, which arc cleared in ¢onlpicx wilh their ill- 
hibilors [161, 
No comp¢lition of t-F'A-PAI-I bintlittg was observed 
when citller u-PA or u-PA-PAI- I  complex was pre.~¢11t 
in excess, This suggests that the receptor identified hcrc 
is distinct from the well-characterized u-PA receptor 
[171. Thi,s distillcti(m was confirnwd by the lack of bin- 
ditag of t-PA-PAI-I complex to the histiocytic lynl- 
plloma cell line U937, a cell line on which the u-PA 
receptor occurs, A further point of contrast is that the 
u-PA receptor e×hibits species specificity [18], while 
humati t-PA.PAI-1 complex bound with equal affinity 
to the receptor on human or rat hepatocytes. 
This study on primary human hepatocytes indicates 
that receptor function recovers from the coilagenase 
treatment used in their isolation [15]. The results 
achieved with hepatoeytes could be reproduced ustng 
suspensions of the hum¢,,n hepatoma cell line, Hep G2. 
It has previously been reported that Hep G2 cells bind 
and take up t-PA [19]. The bindirtg data for t-PA were 
similar to those reported here; binding required com- 
plex formation with the PAI-1 that abounds in the ex- 
tracellular matrix of thdse cells [11]. By using 
suspensions of Hep G2 cells, to avoid interference by 
matrix PAl- l ,  and pro-formed t-PA-PAI-I complex, 
we have been able to show directly that the complex is 
the species recognized by this hepatic receptor. We sug- 
gest that this receptor represents an important 
mechanism for the clearance of endogenous t-PA, 
which occurs in plasma as t-PA-PAI-1 complex [20]. 
Definition of the relative importance of this receptor 
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